Bioxyne to Release Shares From Escrow; Shares Up 17%
Bioxyne (ASX:BXN) said 1.23 billion of its ordinary shares will be released from escrow on May 19. Major shareholders holding 1 billion shares agreed to a further 12-month voluntary escrow to May 19,
Bioxyne to Raise AU$1.45 Million via Share Issuance
Bioxyne (ASX:BXN) received firm commitments to raise AU$1.45 million through the issuance of 145 million new shares at AU$0.01 apiece, according to a Thursday filing with the Australian bourse. The is
Stocks of the Hour: Dotz Nano, Bioxyne, Castle Minerals, Linius Technologies
Dotz Nano (ASX:DTZ) has secured up to $12 million in funding with the Mercer Street Global Opportunity Fund, a US-based investment fund managed by Mercer Street Capital Partners. The funds raised will
Bioxyne Receives License to Manufacture Medical Cannabis, MDMA; Shares Up 50%
Health and wellness products company Bioxyne (ASX:BXN), through its subsidiary Breathe Life Sciences, has been awarded a Good Manufacturing Practice license to manufacture medical cannabis. The licens
Bioxyne Unit Joins Forces to Launch B2B Cannabis Trading Platform in Australia; Shares Slump 11%
Bioxyne's (ASX:BXN) subsidiary, Breathe Life Sciences, partnered with technology firm CanXChange to launch a business-to-business wholesale trading platform in Australia slated to go live by the fourt
No Data